142 related articles for article (PubMed ID: 15720290)
21. Microcystin-LR and okadaic acid-induced cellular effects: a dualistic response.
Gehringer MM
FEBS Lett; 2004 Jan; 557(1-3):1-8. PubMed ID: 14741332
[TBL] [Abstract][Full Text] [Related]
22. Phosphorylation and activation of phosphodiesterase type 3B (PDE3B) in adipocytes in response to serine/threonine phosphatase inhibitors: deactivation of PDE3B in vitro by protein phosphatase type 2A.
Resjö S; Oknianska A; Zolnierowicz S; Manganiello V; Degerman E
Biochem J; 1999 Aug; 341 ( Pt 3)(Pt 3):839-45. PubMed ID: 10417351
[TBL] [Abstract][Full Text] [Related]
23. Neurotoxic and synaptic effects of okadaic acid, an inhibitor of protein phosphatases.
Tapia R; Peña F; Arias C
Neurochem Res; 1999 Nov; 24(11):1423-30. PubMed ID: 10555783
[TBL] [Abstract][Full Text] [Related]
24. [Algal toxins, inhibitors of serine/threonine phosphatases].
Huynh-Delerme C; Puiseux-Dao S
C R Seances Soc Biol Fil; 1998; 192(3):387-408. PubMed ID: 9759380
[TBL] [Abstract][Full Text] [Related]
25. 19-epi-okadaic acid, a novel protein phosphatase inhibitor with enhanced selectivity.
Cruz PG; Daranas AH; Fernández JJ; Norte M
Org Lett; 2007 Aug; 9(16):3045-8. PubMed ID: 17630753
[TBL] [Abstract][Full Text] [Related]
26. Activation of peripheral large granular lymphocytes with the serine/threonine phosphatase inhibitor, okadaic acid.
McVicar DW; Mason AT; Bere EW; Ortaldo JR
Eur J Immunol; 1994 Jan; 24(1):165-70. PubMed ID: 8020552
[TBL] [Abstract][Full Text] [Related]
27. Self-association of okadaic acid: structural and pharmacological significance.
Cruz PG; Norte M; Creus AH; Fernández JJ; Daranas AH
Mar Drugs; 2013 May; 11(6):1866-77. PubMed ID: 23760016
[TBL] [Abstract][Full Text] [Related]
28. The use of okadaic acid to elucidate the intracellular role(s) of protein phosphatase 2A: lessons from the mast cell model system.
Boudreau RT; Hoskin DW
Int Immunopharmacol; 2005 Sep; 5(10):1507-18. PubMed ID: 16023602
[TBL] [Abstract][Full Text] [Related]
29. Abbreviated cell cycle progression induced by the serine/threonine protein phosphatase inhibitor okadaic acid at concentrations that promote neoplastic transformation.
Messner DJ; Ao P; Jagdale AB; Boynton AL
Carcinogenesis; 2001 Aug; 22(8):1163-72. PubMed ID: 11470744
[TBL] [Abstract][Full Text] [Related]
30. Relationship between phosphatase activity and cytotoxic effect of two protein phosphatase inhibitors, okadaic acid and pervanadate, on human myeloid leukemia cell line.
Freire AC; Aoyama H; Haun M; Ferreira CV
J Enzyme Inhib Med Chem; 2003 Oct; 18(5):425-9. PubMed ID: 14692510
[TBL] [Abstract][Full Text] [Related]
31. Okadaic acid-induced decrease in the magnitude and efficacy of the Ca2+ signal in pancreatic beta cells and inhibition of insulin secretion.
Sato Y; Mariot P; Detimary P; Gilon P; Henquin JC
Br J Pharmacol; 1998 Jan; 123(1):97-105. PubMed ID: 9484859
[TBL] [Abstract][Full Text] [Related]
32. Caspase-3 is actively involved in okadaic acid-induced lens epithelial cell apoptosis.
Li DW; Xiang H; Mao YW; Wang J; Fass U; Zhang XY; Xu C
Exp Cell Res; 2001 Jun; 266(2):279-91. PubMed ID: 11399056
[TBL] [Abstract][Full Text] [Related]
33. A molecular modeling analysis of the binding interactions between the okadaic acid class of natural product inhibitors and the Ser-Thr phosphatases, PP1 and PP2A.
Gauss CM; Sheppeck JE; Nairn AC; Chamberlin R
Bioorg Med Chem; 1997 Sep; 5(9):1751-73. PubMed ID: 9354231
[TBL] [Abstract][Full Text] [Related]
34. The protein phosphatase 1/2A inhibitor okadaic acid increases CREB and Elk-1 phosphorylation and c-fos expression in the rat striatum in vivo.
Choe ES; Parelkar NK; Kim JY; Cho HW; Kang HS; Mao L; Wang JQ
J Neurochem; 2004 Apr; 89(2):383-90. PubMed ID: 15056282
[TBL] [Abstract][Full Text] [Related]
35. Hyperphosphorylation of beta-catenin on serine-threonine residues and loss of cell-cell contacts induced by calyculin A and okadaic acid in human epidermal cells.
Serres M; Grangeasse C; Haftek M; Durocher Y; Duclos B; Schmitt D
Exp Cell Res; 1997 Feb; 231(1):163-72. PubMed ID: 9056423
[TBL] [Abstract][Full Text] [Related]
36. Inhibitors of serine/threonine phosphoprotein phosphatases alter circadian properties in Gonyaulax polyedra.
Comolli J; Taylor W; Rehman J; Hastings JW
Plant Physiol; 1996 May; 111(1):285-91. PubMed ID: 8685268
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics.
Bialojan C; Takai A
Biochem J; 1988 Nov; 256(1):283-90. PubMed ID: 2851982
[TBL] [Abstract][Full Text] [Related]
38. Stimulation of hepatocyte growth factor production in human fibroblasts by the protein phosphatase inhibitor okadaic acid.
Gohda E; Nagao T; Yamamoto I
Biochem Pharmacol; 2000 Nov; 60(10):1531-7. PubMed ID: 11020456
[TBL] [Abstract][Full Text] [Related]
39. Inhibitors of phosphoprotein phosphatases 1 and 2A cause activation of a 53 kDa protein kinase accompanying the apoptotic response of breast cancer cells.
Rossini GP; Pinna C; Viviani R
FEBS Lett; 1997 Jun; 410(2-3):347-50. PubMed ID: 9237660
[TBL] [Abstract][Full Text] [Related]
40. Structurally different members of the okadaic acid class selectively inhibit protein serine/threonine but not tyrosine phosphatase activity.
Suganuma M; Fujiki H; Okabe S; Nishiwaki S; Brautigan D; Ingebritsen TS; Rosner MR
Toxicon; 1992 Aug; 30(8):873-8. PubMed ID: 1326138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
